DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bonneterre J, Thürlimann B, Robertson JF, Krzakowski M, Mauriac L, Koralewski P. et al.
Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: Results of the Tamoxifen or Arimidex Randomized Group (TARGET) efficacy and tolerability study.
J Clin Oncol 2000; 18: 3748-3757
We do not assume any responsibility for the contents of the web pages of other providers.